Congressional record
Jefferson Shreve sold AbbVie Inc. stock on APR 17, 2025.
Jefferson Shreve — a trade near an FDA decision
The FDA approved a product from AbbVie Inc. on APR 15, 2025.
2 days separated the trade and the FDA action.
10 of Shreve's disclosed trades fall within three weeks of an FDA decision.
Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
SOURCE: STOCK ACT DISCLOSURES, HOUSE CLERK · OPENFDA, U.S. FOOD & DRUG ADMINISTRATION